trending Market Intelligence /marketintelligence/en/news-insights/trending/wlpjsu3tlywmlkmdhevfka2 content esgSubNav
In This List

Cutera's nonsurgical fat removal system gets US FDA clearance for expanded use

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints


Cutera's nonsurgical fat removal system gets US FDA clearance for expanded use

The U.S. Food and Drug Administration cleared Cutera Inc.'s nonsurgical body sculpting system truSculpt 3D for lipolysis, or the breakdown of fat.

The device previously has FDA clearance for the reduction of fat without surgery.

Brisbane, Calif.-based Cutera is a medical device company that designs, develops, manufactures, markets and services laser and other energy-based aesthetics systems worldwide.